Agilent Technologies Inc
A113.500USD
-1.310-1.14%
Close 08/01, 16:00（ET）Quotes delayed by 15 min
32.23BMarket Cap
27.64P/E TTM
More Details of Agilent Technologies Inc Company
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Company Info
Ticker SymbolA
Company nameAgilent Technologies Inc
IPO dateNov 18, 1999
Founded at1999
CEOMr. Padraig Mcdonnell
Number of employees17900
Security typeOrdinary Share
Fiscal year-endNov 18
Address5301 Stevens Creek Blvd
CitySANTA CLARA
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code95051
Phone14083458886
Websitehttps://www.agilent.com/
Ticker SymbolA
IPO dateNov 18, 1999
Founded at1999
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Boon Hwee Koh
Mr. Boon Hwee Koh
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
61.55K
+2.11%
Mr. Rodney Gonsalves
Mr. Rodney Gonsalves
Interim Chief Financial Officer, Principal Accounting Officer, Vice President, Corporate Controller
Interim Chief Financial Officer, Principal Accounting Officer, Vice President, Corporate Controller
48.45K
+22.91%
Dr. George A. Scangos, Ph.D.
Dr. George A. Scangos, Ph.D.
Independent Director
Independent Director
38.35K
+4.98%
Dr. Daniel K. Podolsky, M.D.
Dr. Daniel K. Podolsky, M.D.
Independent Director
Independent Director
35.68K
--
Mr. Dow R. Wilson
Mr. Dow R. Wilson
Independent Director
Independent Director
18.04K
+11.21%
Ms. Mala Anand
Ms. Mala Anand
Independent Director
Independent Director
14.55K
+14.29%
Dr. Otis W. Brawley, M.D.
Dr. Otis W. Brawley, M.D.
Independent Director
Independent Director
10.73K
+32.49%
Mr. Padraig Mcdonnell
Mr. Padraig Mcdonnell
Chief Executive Officer, Director
Chief Executive Officer, Director
10.26K
-12.81%
Dr. Mikael G. Dolsten, M.D., Ph.D.
Dr. Mikael G. Dolsten, M.D., Ph.D.
Independent Director
Independent Director
7.54K
+31.77%
Dr. Simon May
Dr. Simon May
Senior Vice President, President, Diagnostics and Genomics
Senior Vice President, President, Diagnostics and Genomics
7.32K
-4.79%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Boon Hwee Koh
Mr. Boon Hwee Koh
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
61.55K
+2.11%
Mr. Rodney Gonsalves
Mr. Rodney Gonsalves
Interim Chief Financial Officer, Principal Accounting Officer, Vice President, Corporate Controller
Interim Chief Financial Officer, Principal Accounting Officer, Vice President, Corporate Controller
48.45K
+22.91%
Dr. George A. Scangos, Ph.D.
Dr. George A. Scangos, Ph.D.
Independent Director
Independent Director
38.35K
+4.98%
Dr. Daniel K. Podolsky, M.D.
Dr. Daniel K. Podolsky, M.D.
Independent Director
Independent Director
35.68K
--
Mr. Dow R. Wilson
Mr. Dow R. Wilson
Independent Director
Independent Director
18.04K
+11.21%
Ms. Mala Anand
Ms. Mala Anand
Independent Director
Independent Director
14.55K
+14.29%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Non-instrumentation and other
1.12B
67.03%
Instrumentation
550.00M
32.97%
By RegionUSD
Name
Revenue
Proportion
United States
678.00M
40.65%
Asia Pacific
548.00M
32.85%
Europe
442.00M
26.50%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Non-instrumentation and other
1.12B
67.03%
Instrumentation
550.00M
32.97%
Shareholding Stats
Updated: Thu, May 15
Updated: Thu, May 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.72%
BlackRock Institutional Trust Company, N.A.
5.41%
State Street Global Advisors (US)
4.44%
MFS Investment Management
3.87%
Wellington Management Company, LLP
3.14%
Other
71.43%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.72%
BlackRock Institutional Trust Company, N.A.
5.41%
State Street Global Advisors (US)
4.44%
MFS Investment Management
3.87%
Wellington Management Company, LLP
3.14%
Other
71.43%
Shareholder Types
Shareholders
Proportion
Investment Advisor
44.06%
Investment Advisor/Hedge Fund
34.43%
Hedge Fund
4.41%
Research Firm
1.97%
Pension Fund
1.82%
Insurance Company
1.66%
Bank and Trust
1.57%
Sovereign Wealth Fund
1.30%
Family Office
0.44%
Other
8.34%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
2097
260.64M
91.75%
-4.22M
2025Q1
2174
262.93M
92.55%
-7.77M
2024Q4
2144
261.66M
91.77%
-9.44M
2024Q3
2092
261.54M
91.00%
-12.94M
2024Q2
2065
263.61M
90.36%
-18.36M
2024Q1
2066
270.62M
92.35%
-9.44M
2023Q4
2084
269.59M
92.01%
-3.30M
2023Q3
2017
262.63M
89.76%
-13.56M
2023Q2
2002
268.16M
90.78%
-20.64M
2023Q1
1985
271.86M
91.93%
-13.10M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
33.28M
11.72%
+239.78K
+0.73%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
15.37M
5.41%
+39.00K
+0.25%
Mar 31, 2025
State Street Global Advisors (US)
12.61M
4.44%
-104.71K
-0.82%
Mar 31, 2025
MFS Investment Management
10.98M
3.87%
-512.88K
-4.46%
Mar 31, 2025
Wellington Management Company, LLP
8.93M
3.14%
-376.03K
-4.04%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
7.60M
2.68%
-629.16K
-7.65%
Mar 31, 2025
Geode Capital Management, L.L.C.
7.20M
2.54%
+201.68K
+2.88%
Mar 31, 2025
Pictet Asset Management Ltd.
5.34M
1.88%
+128.13K
+2.46%
Mar 31, 2025
Generation Investment Management LLP
4.98M
1.75%
+824.24K
+19.82%
Mar 31, 2025
State Farm Insurance Companies
4.52M
1.59%
--
--
Mar 31, 2025
View more
Related ETFs
Updated: 10 hours ago
Updated: 10 hours ago
Name
Proportion
Honeytree US Equity ETF
4.01%
First Trust Water ETF
3.56%
VanEck Morningstar Wide Moat Growth ETF
2.44%
VanEck Morningstar Wide Moat ETF
2.38%
Global X Genomics & Biotechnology ETF
2.2%
First Trust Indxx Medical Devices ETF
2.15%
Invesco Raymond James SB-1 Equity ETF
2.12%
Argent Mid Cap ETF
2.1%
iShares Health Innovation Active ETF
2.01%
Invesco S&P 500 Equal Weight Health Care ETF
1.63%
View more
Honeytree US Equity ETF
Proportion4.01%
First Trust Water ETF
Proportion3.56%
VanEck Morningstar Wide Moat Growth ETF
Proportion2.44%
VanEck Morningstar Wide Moat ETF
Proportion2.38%
Global X Genomics & Biotechnology ETF
Proportion2.2%
First Trust Indxx Medical Devices ETF
Proportion2.15%
Invesco Raymond James SB-1 Equity ETF
Proportion2.12%
Argent Mid Cap ETF
Proportion2.1%
iShares Health Innovation Active ETF
Proportion2.01%
Invesco S&P 500 Equal Weight Health Care ETF
Proportion1.63%
Dividend
A total of
1.25B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Nov 20, 2024
A.NB Interim Cash Dividend of gross USD 0.248 paid on Jan 22, 2025 going ex on Dec 31, 2024 with reinvestment option
Dec 31, 2024
Jan 22, 2025
Dec 31, 2024
Sep 18, 2024
A.NB Final Cash Dividend of gross USD 0.236 paid on Oct 23, 2024 going ex on Oct 01, 2024 with reinvestment option
Oct 01, 2024
Oct 23, 2024
Oct 01, 2024
May 22, 2024
A.NB Interim Cash Dividend of gross USD 0.236 paid on Jul 24, 2024 going ex on Jul 02, 2024
Jul 02, 2024
Jul 24, 2024
Jul 02, 2024
Feb 21, 2024
A.NB Interim Cash Dividend of gross USD 0.236 paid on Apr 24, 2024 going ex on Apr 01, 2024
Apr 02, 2024
Apr 24, 2024
Apr 01, 2024
Nov 16, 2023
A.NB Interim Cash Dividend of gross USD 0.236 paid on Jan 24, 2024 going ex on Dec 29, 2023
Jan 02, 2024
Jan 24, 2024
Dec 29, 2023
Sep 21, 2023
A.NB Final Cash Dividend of gross USD 0.225 paid on Oct 25, 2023 going ex on Oct 02, 2023 with reinvestment option
Oct 03, 2023
Oct 25, 2023
Oct 02, 2023
May 18, 2023
A.NB Interim Cash Dividend of gross USD 0.225 paid on Jul 26, 2023 going ex on Jun 30, 2023 with reinvestment option
Jul 03, 2023
Jul 26, 2023
Jun 30, 2023
Feb 22, 2023
A.NB Interim Cash Dividend of gross USD 0.225 paid on Apr 26, 2023 going ex on Apr 03, 2023
Apr 04, 2023
Apr 26, 2023
Apr 03, 2023
Nov 16, 2022
A.NB Interim Cash Dividend of gross USD 0.225 paid on Jan 25, 2023 going ex on Dec 30, 2022
Jan 03, 2023
Jan 25, 2023
Dec 30, 2022
Sep 21, 2022
A.NB Final Cash Dividend of gross USD 0.21 paid on Oct 26, 2022 going ex on Oct 03, 2022
Oct 04, 2022
Oct 26, 2022
Oct 03, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
